17 participants
Avelumab in G2-3 NET
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-24
- Start Date:
- 2017-11-15
- Completion:
- 2021-07-26
Conditions
- Neuroendocrine Tumors
Interventions
- DRUG
No Results Yet